No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival.
The prognostic improvement attributed to genetic markers over current prognostic system has not been well studied for melanoma. The goal of this study is to evaluate the added prognostic value of Vitamin D Pathway (VitD) SNPs to currently known clinical and demographic factors such as age, sex, Bres...
Saved in:
| Main Authors: | Li Luo, Irene Orlow, Peter A Kanetsky, Nancy E Thomas, Shenying Fang, Jeffrey E Lee, Marianne Berwick, Ji-Hyun Lee, GEM Study Group |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0174234 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Solar elastosis correlates with high tumor mutation burden and better 5-year disease-specific survival in patients with stage II/III melanoma
by: Cecilia Lezcano, et al.
Published: (2024-12-01) -
Complete response as prognostic marker of prolonged survival in metastatic melanoma
by: D. Bafaloukos, et al.
Published: (2024-01-01) -
Survival expectations in melanoma patients: a molecular prognostic model associated with aging
by: Nenghua Zhang, et al.
Published: (2025-02-01) -
Novel Prognostic Markers for Skin Cutaneous Melanoma
by: Zhang Y, et al.
Published: (2024-11-01) -
Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
by: Katarzyna Borys, et al.
Published: (2025-05-01)